Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04006470 · ClinicalTrials.gov registry record
Meta-analysis of Stannous Fluoride and the Effects on Enamel Erosion
A clinical trial of Enamel Erosion, sponsored by Procter and Gamble.
- Completed
- Registry status
- 172
- Enrollment target
- 1
- Study location
NCT04006470: Completed study of Enamel Erosion, sponsored by Procter and Gamble.
NCT04006470 is a study of Enamel Erosion that has completed, run by Procter and Gamble. The registered enrollment target is 172 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04006470, a study of Enamel Erosion, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- 172 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this 5 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) dentifrices to assess enamel erosion protection in-situ using surface profilometry.
Primary Outcome
Enamel samples will be measured via profilometry after 10 days of study use.
Conditions Studied
Interventions
- DRUG Stannous fluoride dentifrice
- DRUG Positive control dentifrice
- DRUG Negative control dentifrice
Study Locations (1)
Ohio
- Multiple P&G Investigation Clinical Sites - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2018-01-08 |
| Est. Completion | 2018-11-30 |
What the finished NCT04006470 record still lists
NCT04006470 is an observational study that tracks outcomes without assigning an intervention. The registered 172 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Enamel Erosion appearing as the primary indexed condition, and to 3 interventions - of which Stannous fluoride dentifrice is the first listed.
NCT04006470 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04006470 about?
NCT04006470 is a clinical study titled "Meta-analysis of Stannous Fluoride and the Effects on Enamel Erosion". The aim of this 5 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) dentifrices to assess enamel erosion protection in-situ using surface profilometry.
What is the current status of trial NCT04006470?
This trial is currently completed. The enrollment target is 172 participants. The study started on 2018-01-08. Estimated completion is 2018-11-30.
What conditions does trial NCT04006470 study?
This clinical trial studies the following conditions: Enamel Erosion.
What interventions are being tested in trial NCT04006470?
The interventions under investigation include: Stannous fluoride dentifrice (DRUG), Positive control dentifrice (DRUG), Negative control dentifrice (DRUG).
Who is sponsoring clinical trial NCT04006470?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04006470 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Enamel Erosion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04801797 · 172 participants · Phase 2
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
- NCT04867317 · 172 participants · Phase 3
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
- NCT05357040 · 172 participants · Phase 2
Antidepressant Effects of Nitrous Oxide
- NCT05587517 · 172 participants · Phase 2
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI